ARCHIVES

Sponsors Withdraw Indications for Iressa, Celebrex

This article is from The Cancer Letter archive.

Vol. 37 No. 06 | February 11, 2011

Download PDF Visit The Full Archive

Related Articles

As Avastin Decision Nears, Patient Groups Split On PFS In Front Line Breast Cancer.

February 22, 2008

Academic Oncologists Losing Control Over Phase I Trials As For-Profits Expand

March 26, 2010

Congress Urges CMS To Soften Proposal For Coverage Of ESAs in Oncology.

July 20, 2007

National Coalition An Education Group, Chairman Says

May 3, 1985

Center Directors To Hear “Creative” Approach to Funding Cancer Control

February 25, 1983

NCI Issues 8 Awards, 12 Feasibility Grants, In New SPORE Program

October 9, 1992